IFNB1 and neuroblastoma: More investigations are required to understand the effects of OEA and PEA combined with IFNβ on different human neuroblastoma cell lines; nevertheless, our study offers substantial and novel data emphasizing the promising use of PPARα receptor agonists as possible new therapeutic targets to accompany, in the future, classical cancer therapy.